Business
Director dealing
EDX Medical Group plc announced that Professor Sir Christopher Evans, founder and Chief Scientific Officer, purchased 41,780 ordinary shares on January 8, 2026, at 13.00 pence per share, following previous share purchases on January 2 and January 5, 2026. This latest transaction brings his total ownership to 136,161,523 shares, representing 35.22% of the issued share capital. Disclaimer*
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n\n \n \n9 January 2026\nEDX Medical Group plc · EDX\nAQSE: EDX\n(\"EDX Medical\" or the \"Company\")\n \nDirector dealing\n \nCAMBRIDGE, UK: EDX Medical Group plc (\"EDX Medical\", the \"Company\" or the \"Group\"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that Professor Sir Christopher Evans, founder and Chief Scientific Officer of the Company, purchased 41,780 ordinary shares in the Company on January 8, 2026, at a price per share of 13.00 pence.\n \nThis transaction follows the purchase by Professor Evans of 45,500 ordinary shares in the Company, as announced on January 5, 2026, and the earlier purchase of 57,304 ordinary shares in the Company, as announced on January 2, 2026.\n \nProfessor Evans now owns 136,161,523 shares in the Company, representing 35.22% of the issued share capital.\n \nThe directors of the Company accept responsibility for the contents of this announcement.\n \n \n\n\n\n\n1\n \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n \n\n\n\n\na)\n \n\n\nName\n \n\n\nProfessor Sir Christopher Evans\n\n\n\n\n2\n \n\n\nReason for the notification\n \n\n\n\n\na)\n \n\n\nPosition/status\n \n\n\nBoard Director / Chief Scientific Officer\n\n\n\n\nb)\n \n\n\nInitial notification /Amendment\n \n\n\nInitial notification\n\n\n\n\n3\n \n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n\n\n\n\na)\n \n\n\nName\n \n\n\nEDX Medical Group plc\n\n\n\n\nb)\n \n\n\nLEI\n \n\n\n213800BZVJZTMCZ6DJ63\n\n\n\n\n4\n \n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n\n\n\n\na)\n \n\n\nDescription of the financial instrument, type of instrument\n\n\nOrdinary Shares of £0.01 each\n\n\n\n\nIdentification code\n\n\nISIN: GB00BNDMJS47\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nb)\n \n\n\nNature of the transaction\n \n \n\n\nPurchase of shares on mar...